s-adenosylmethionine has been researched along with tamoxifen in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehal, SS; Kupfer, D | 1 |
| Ahn, SG; Kang, KW; Kim, HS; Kim, SK; Kim, TH; Lee, KY; Lim, SC; Phuong, NT; Yoon, JH | 1 |
| Kang, KW; Kim, SK; Kwak, HC; Lee, JY; Oh, SJ; Phuong, NT; Ryu, CS | 1 |
| Choi, MC; Im, JH; Kang, KW; Kim, SK; Kim, YM; Lee, KY; Lim, SC; Phuong, NT; Yang, JW; Yoon, JH | 1 |
| Caudal, A; Kolwicz, SC; McMillen, TS; Ritterhoff, J; Senn, T; Tian, R; Villet, O; Young, S | 1 |
5 other study(ies) available for s-adenosylmethionine and tamoxifen
| Article | Year |
|---|---|
Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins.
Topics: Animals; Antineoplastic Agents, Hormonal; Biotransformation; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cytochrome P-450 Enzyme System; Female; Hydroxylation; Male; Microsomes, Liver; Phenobarbital; Pregnenolone Carbonitrile; Rats; Rats, Sprague-Dawley; S-Adenosylhomocysteine; S-Adenosylmethionine; Tamoxifen | 1996 |
Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Azacitidine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Resistance, Neoplasm; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; PTEN Phosphohydrolase; S-Adenosylmethionine; Tamoxifen; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
Elevation of cysteine consumption in tamoxifen-resistant MCF-7 cells.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cystathionine gamma-Lyase; Cysteine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Glutamate-Cysteine Ligase; Glutathione; Humans; Membrane Transport Modulators; Methionine; Methylation; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; S-Adenosylhomocysteine; S-Adenosylmethionine; Tamoxifen; Taurine; Up-Regulation | 2013 |
Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; DNA Methylation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Methionine Adenosyltransferase; MicroRNAs; NF-E2-Related Factor 2; NF-kappa B; Promoter Regions, Genetic; PTEN Phosphohydrolase; S-Adenosylmethionine; Signal Transduction; Tamoxifen; Transcription Factor AP-1; Tumor Cells, Cultured | 2016 |
Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts.
Topics: Acetyl-CoA Carboxylase; Animals; Carnitine; Disease Models, Animal; Energy Metabolism; Fatty Acids; Female; Gene Deletion; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Oxidation-Reduction; PPAR alpha; Sex Factors; Signal Transduction; Tamoxifen | 2021 |